Skip to main content
Beth Israel Deaconess Medical Center Harvard Medical School Teaching Hospital
Heng Lab
Primary menu
  • About
  • PI Bio
  • Members
  • News
  • Publications

Contact

  1. Home

Heng Lab

330 Brookline Ave
Boston MA 02115

tc

Bridging the gap between molecular biology and clinical utility

Our research programs are unified by a single focus: understanding breast cancer biology across the disease continuum. From identifying the earliest tissue changes to decoding the intrinsic factors governing therapeutic response, we design the tools that define the future of oncology.

Learn about our research

Recent Publications

  • Oral contraceptive use and the expression of stromal markers in benign breast tissue
  • Subtype-Specific Associations of Computational Stromal Tumor-Infiltrating Lymphocytes with Breast Cancer Outcomes
  • African Green Monkey Cerebrospinal Fluid miRNome Captures Conserved miRNAs Relevant to Human Neurodegenerative Disease
  • Associations of alcohol use with expression of stromal markers in benign breast biopsy samples.
  • The miR-362-3p/BCLAF1 axis regulates cisplatin sensitivity and metastatic progression in triple-negative breast cancer
  • MicroRNA spatial profiling for assessing drug efficacy in BRCA1-related triple-negative breast tumors
More

Latest News

  • MLSC Frontiers Award 2026

    July 11, 2026
  • HMS Pathology Retreat 2026

    June 15, 2026
  • HiRM RNA Technology Showcase - Mirxes

    May 12, 2026
More
Powered byOpenScholar®Admin Login
Beth Israel Deaconess Medical Center Harvard Medical School Teaching Hospital